News & Events

Rob Rosenbaum was an experienced investor in technology companies when he joined the Maryland Technology Development Corporation (TEDCO) in 2010 as its executive director. “I had spent most of my career in small and growing companies,” he recalled. That experience proved to be crucial in his time as

Hememics Biotechnologies, Inc., is using graphene monolayer biosensors to revolutionize point-of-care testing for viruses and environmental toxins. The HemBox™, a cellphone-sized reader and chip platform, allows users to test for multiple viruses and toxins from samples as diverse as soil, water

New agreement will allow more collaboration to advance technology and life sciences innovations across the state

TEDCO kicked off the summer with more than $500,000 in investments backing multiple burgeoning biotech companies in support of Maryland’s growing life sciences ecosystem.